Fact check
“In 69% of prescription drug labels, reporters found a generic drug manufacturer’s DUNS number.”
Reasoning
The ProPublica article states that reporters, while collecting data for the Rx Inspector tool, found a generic drug manufacturer’s DUNS number on 69% of prescription drug labels and could link it to a specific facility. This directly confirms the claim.
On confidence: The claim is directly quoted in the provided ProPublica article excerpt.
Important context
The statistic refers to the proportion of prescription drug labels where a generic manufacturer’s DUNS number was identified by reporters using the Rx Inspector tool.
Evidence
Supporting (2)
- Tier 1 — Primary sourceClear Labels Act Stripped of Critical Drug Safety Provisions — ProPublica
the bill’s updated language, drug labels will only be required to include factory addresses, which can be inconsistent and hard to trace to a manufacturing facility. A single address in India, for example, can house multiple factories,…
- Tier 1 — Primary sourceClear Labels Act Stripped of Critical Drug Safety Provisions — ProPublica
are already using the tool to learn more about the drugs they take and prescribe . Under the bill’s updated language, drug labels will only be required to include factory addresses, which can be inconsistent and hard to trace to a…
Limitations
The evidence is limited to the single ProPublica source; no additional independent verification is provided.
- Last verified:
- Sep 27, 2026, 4:24 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
“A Clear Watering Down”: Drug Transparency Bill Stripped of Critical Provisions Ahead of Senate VoteProPublica · Naisha Roy